<VariationArchive VariationID="217835" VariationName="NM_000256.3(MYBPC3):c.1359del (p.Val454fs)" VariationType="Deletion" Accession="VCV000217835" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2015-11-14" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="214491" VariationID="217835">
      <GeneList>
        <Gene Symbol="MYBPC3" FullName="myosin binding protein C3" GeneID="4607" HGNC_ID="HGNC:7551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47331406" stop="47352702" display_start="47331406" display_stop="47352702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47352956" stop="47374252" display_start="47352956" display_stop="47374252" Strand="-" />
          </Location>
          <OMIM>600958</OMIM>
          <Haploinsufficiency last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-01-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MYBPC3">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000256.3(MYBPC3):c.1359del (p.Val454fs)</Name>
      <CanonicalSPDI>NC_000011.10:47342927:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="47342928" stop="47342928" display_start="47342928" display_stop="47342928" variantLength="1" positionVCF="47342927" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="47364479" stop="47364479" display_start="47364479" display_stop="47364479" variantLength="1" positionVCF="47364478" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>V454fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_386" sequenceAccession="LRG_386" change="g.14775del">
            <Expression>LRG_386:g.14775del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_386t1" sequenceAccession="LRG_386t1" change="c.1359del">
            <Expression>LRG_386t1:c.1359del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_386p1" sequenceAccession="LRG_386p1" change="p.Val454fs">
            <Expression>LRG_386p1:p.Val454fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.47342928del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.47342928del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.47364479del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.47364479del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007667.1" sequenceAccession="NG_007667" sequenceVersion="1" change="g.14775del">
            <Expression>NG_007667.1:g.14775del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000256.3" sequenceAccession="NM_000256" sequenceVersion="3" change="c.1359del" MANESelect="true">
            <Expression>NM_000256.3:c.1359del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000247.2" sequenceAccession="NP_000247" sequenceVersion="2" change="p.Val454fs">
            <Expression>NP_000247.2:p.Val454fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000256.3" sequenceAccession="NM_000256" sequenceVersion="3" change="c.1359delT" MANESelect="true">
            <Expression>NM_000256.3:c.1359delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA279624" DB="ClinGen" />
        <XRef Type="rs" ID="863225271" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1359del (p.Val454fs) AND Hypertrophic cardiomyopathy 1" Accession="RCV000201912" Version="2">
        <ClassifiedConditionList TraitSetID="6411">
          <ClassifiedCondition DB="MedGen" ID="C3495498">Hypertrophic cardiomyopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000256.3(MYBPC3):c.1359del (p.Val454fs) AND Hypertrophic cardiomyopathy" Accession="RCV001209345" Version="9">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-13" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-11-14" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19574547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25351510</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27532257</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28615295</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1311" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYH7-Related Familial Hypertrophic Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypertrophic cardiomyopathy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 1</ElementValue>
                <XRef ID="MONDO:0008647" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH1</ElementValue>
                <XRef Type="MIM" ID="192600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypertrophic cardiomyopathy (HCM) is typically defined by the presence of unexplained left ventricular hypertrophy (LVH). Such LVH occurs in a non-dilated ventricle in the absence of other cardiac or systemic disease capable of producing the observed magnitude of increased LV wall thickness, such as pressure overload (e.g., long-standing hypertension, aortic stenosis) or storage/infiltrative disorders (e.g., Fabry disease, amyloidosis). The clinical manifestations of HCM range from asymptomatic LVH to progressive heart failure to sudden cardiac death (SCD), and vary from individual to individual even within the same family. Common symptoms include shortness of breath (particularly with exertion), chest pain, palpitations, orthostasis, presyncope, and syncope. Most often the LVH of HCM becomes apparent during adolescence or young adulthood, although it may also develop late in life, in infancy, or in childhood.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="CUI, rejected">C0949658</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301725</ID>
                <ID Source="BookShelf">NBK1768</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21267010</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C3495498" DB="MedGen" />
              <XRef ID="MONDO:0008647" DB="MONDO" />
              <XRef Type="MIM" ID="192600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="479125" SubmissionDate="2015-08-25" DateLastUpdated="2015-11-14" DateCreated="2015-11-14">
        <ClinVarSubmissionID localKey="VAR0000132|OMIM:192600" />
        <ClinVarAccession Accession="SCV000256658" DateUpdated="2015-11-14" DateCreated="2015-11-14" Type="SCV" Version="2" SubmitterName="Agnes Ginges Centre for Molecular Cardiology, Centenary Institute" OrgID="505375" OrganizationCategory="laboratory" OrgAbbreviation="CI-AGCMC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This MYBPC3 Val454Cysfs*12 variant is predicted to cause a frameshift starting at codon 454, and lead to a premature stop codon 11 amino acids downstream. This variant has been identified in our laboratory in a patient with a diagnosis of HCM. Co-segregation data from our laboratory showed that 3 affected individuals in the family all carried the variant. This frameshift variant is not reported in the literature and is not present in both the 1000 genomes project (http://www.1000genomes.org/), and the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). Based on its absence in the general population. familial segregation of the variant with disease in our family, and that loss-of-function mutations in the MYBPC3 gene are an established mechanism of disease in HCM, this variant is categorised by our group as "pathogenic".</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Agnes Ginges Centre for Molecular Cardiology criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/uci8jhha/mdi-5363_505375_agnesginges_variantassess_clinvar.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000256.3:c.1359delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192600" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2715557" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4894687|MedGen:C0007194" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001380775" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25351510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19574547</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 217835). This premature translational stop signal has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 25351510, 27532257). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val454Cysfs*12) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.47364479del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0007194" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9055813" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="98354231|Orphanet:ORPHA217569" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004847805" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27532257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25351510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28615295</ID>
          </Citation>
          <Comment>The p.Val454CysfsX12 variant in MYBPC3 has been reported in 3 individuals with hypertrophic cardiomyopathy and segregated with disease in 2 family members (Lopes 2015, Walsh 2017, Ross 2017). It was absent from large population studies but has been reported in ClinVar (Variation ID 217835). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 454 and leads to a premature termination codon 12 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the MYBPC3 gene is an established disease mechanism in autosomal dominant HCM. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant HCM. ACMG/AMP Criteria applied: PVS1, PM2, PS4_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYBPC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000256.3:exon 16</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.47342928delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA217569" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2715557" TraitType="Disease" MappingType="XRef" MappingValue="C0007194" MappingRef="MedGen">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="479125" TraitType="Disease" MappingType="XRef" MappingValue="192600" MappingRef="OMIM">
        <MedGen CUI="C3495498" Name="Hypertrophic cardiomyopathy 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9055813" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA217569" MappingRef="Orphanet">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

